Jian-da Hu (Jian da Hu, Jianda Hu)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia

Multiple Myeloma

Top Venues

American journal of hematology

Journal of cellular physiology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Jian-Xiang Wang, Bin Jiang, Jian Li, Ligen Liu, Xin Du, Hao Jiang, Jian-da Hu, Menghe Yuan, Taishi Sakatani, Takeshi Kadokura, Masato Takeuchi, Masanori Kosako, Xiao Ma, Larisa Girshova, Jerome Tan, Sergey Bondarenko, Lily Wong Lee Lee, Archrob Khuhapinant, Elena Martynova, Nahla Hasabou
Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia. Leukemia (2024)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Hewen Yin, Shanshan Suo, Wenjuan Yu, Jie Jin
Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. American journal of hematology 99 (4) (2024)
Sen Yang, Xiaoshuai Zhang, Robert Peter Gale, Xin Du, Chun-Yan Chen, Jian-Yu Weng, Jian Huang, Fei Li, Yun Zeng, Zhen Xiao, Jian-da Hu, Li-Jie Yang, Zhuo-Gang Liu, Guo-Hui Li, Xiu-Li Sun, Wei Yang, Ru Feng, Yan-Qiu Han, Yu Jing, Na Xu, Xiao-Li Liu, Zhen-Fang Liu, Xiao-Dong Wang, Shi-Xin Wu, Rong Liang, Yan-Li Zhang, Yun-Fan Yang, Huan-Ling Zhu, Ling Pan, Li Meng, Yan-Hong Zhao, Hai Yi, Yi-Lan Liu, Wei-Hua Zhang, Yuan-Jun Zheng, Ze-Ping Zhou, Su-Ning Chen, Hui-Ying Qiu, Wei-Ming Li, Zhi-Lin Jia, Yan-Liang Bai, Li-E Lin, Bing-Cheng Liu, Chun-Shui Liu, Jian-Min Luo, Jun-Xia Meng, Zhi-Qiang Sun, Yan-Qing Zhang, Xiao-Jun Huang, Qian Jiang
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. American journal of hematology (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology (2023)
Jingjing Wen, Yanxin Chen, Jiajie Yang, Chunye Dai, Shenjie Yu, Wenting Zhong, Lilin Liu, Chengguanng He, Wenmin Zhang, Ting Yang, Lingfeng Liu, Jian-da Hu
Valproic acid increases CAR T cell cytotoxicity against acute myeloid leukemia. Journal for immunotherapy of cancer 11 (7) (2023)
Xiao-Shuai Zhang, Robert Peter Gale, Bingcheng Liu, Jian Huang, Yanli Zhang, Xin Du, Jian-Yu Weng, Weiming Li, Na Xu, Xiaoli Liu, Chunyan Chen, Hai Lin, Guohui Li, Rong Liang, Zhuogang Liu, Xiaodong Wang, Yanqing Zhang, Yanqiu Han, Chunshui Liu, Jian-da Hu, Lie Lin, Wei Yang, Zhenfang Liu, Li Meng, Chuanqing Tu, Caifeng Zheng, Zeping Zhou, Yanliang Bai, Huiying Qiu, Suning Chen, Fei Li, Jianxin Guo, Zelin Liu, Hui Sun, Li Zhou, Ru Feng, Xiuli Sun, Xiao-Jun Huang, Qian Jiang
Validation of the imatinib-therapy failure model. Leukemia (2023)
Yuqin Song, Ke-Shu Zhou, Dehui Zou, Dengju Li, Jian-da Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Dao-Bin Zhou, Constantine S Tam, David Simpson, Michael L Wang, Tycel J Phillips, Stephen Samuel Opat, Cheng Fang, Shaohui Sun, Jun Zhu
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis. Cancer medicine (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Lijuan Deng, Zhi-Ming Li, Huilai Zhang, Haiwen Huang, Jian-da Hu, Lihong Liu, Ting Liu, Jie Jin, Zunmin Zhu, Wenyu Li, Zhenqian Huang, Wenrong Huang, Ke-Shu Zhou, Haiyan Yang, Mingzhi Zhang, Kaiyang Ding, Hui Zhou, Han Yan, Yuerong Shuang, Junning Cao, Sujun Gao, Dengju Li, Zimin Sun, Qingyuan Zhang, Shuhua Yi, Chun-Yan Ji, Liansheng Zhang, Cheng Hou, Yue Du, Weige Wang, Renbin Zhao, Yuqin Song, Jun Zhu
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study. American journal of hematology (2023)
Wei Xu, Ke-Shu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Han Yan, Wei Zhang, Kaiyang Ding, Jian-Feng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jian-da Hu, Chun-Yan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xinran Tang, Bin Zhang, Jianyong Li
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American journal of hematology 98 (4) (2023)
Yi Chen, Luting Luo, Lushan Chen, Xiaoyun Zheng, Xiaozhu Yang, Zhihong Zheng, Jing Zheng, Tingbo Liu, Ting Yang, Jian-da Hu
Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era. Journal of cancer research and clinical oncology (2022)
Yuan-Kai Shi, Qingyuan Zhang, Xiaonan Hong, Zhen Wang, Yuhuan Gao, Liqun Zou, Hong Cen, Lin Gui, Yufu Li, Jifeng Feng, Zhao Wang, Mingzhi Zhang, Chuan Jin, Weihua Zhang, Jian-da Hu, Chengyun Zheng, Zhendong Zheng, Liling Zhang, Shaoshui Chen, Yunhong Huang, Yun Tang, Yajie Gao, Miaowang Hao, Xiaoling Li, Chunkang Chang, Haiyan Yang, Hui Wu, Lida Shen, Xiaoyan Ke, Liangming Zhang, Yaming Xi, Linhua Yang, Liangzhi Xie, Wenlin Gai, Yanan Ji
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera ® ) in combination with CHOP in patients with previously untreated CD20-positive diffuse large B-cell lymphoma: A randomized, single-blind, phase III clinical trial. Hematological oncology (2022)
Yi Zhang, Hu Zhou, Zhongxing Jiang, Dengshu Wu, Junling Zhuang, Wei Li, Qian Jiang, Xiuli Wang, Jinwen Huang, Huan-Ling Zhu, Linhua Yang, Xin Du, Fei Li, Ruixiang Xia, Feng Zhang, Jian-da Hu, Yan Li, Han Yan, Jing Liu, Chenghao Jin, Kai Sun, Zeping Zhou, Liqing Wu, Wenjuan Yu, Jie Jin
Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial. American journal of hematology 97 (12) (2022)
Na Li, Bin Zheng, Hongfu Cai, Ting Yang, Yunda Hong, Maobai Liu, Jian-da Hu
Cost-effectiveness analysis of axicabtagene ciloleucel vs. salvage chemotherapy for relapsed or refractory adult diffuse large B-cell lymphoma in China. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (7) (2022)
Lijin Chen, Luting Luo, Yanxin Chen, Yinzhou Wang, Jing Li, Xiaoyun Zheng, Ting Yang, Jian-da Hu
Antifungal Strategy in Patients with Invasive Fungal Disease Associated with Hematological Malignancies Based on Risk Stratification. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2022 (2022)
Chen Xing Zhao, Jing Jing Wen, Di Fu, Peng Peng Xu, Shu Cheng, Li Wang, Chao Fu Wang, Xiao Chun Fei, Xin Wang, Jian Feng Zhou, Li Ping Su, Zhuo Wen Chen, Jie Ping Chen, Mei Yun Fang, Ting Liu, Yong Ping Song, Kang Yu, Yan Li, Jian Gu, Ming Hou, Wei Li Zhao, Jian-da Hu
Clinical and molecular features of Epstein-Barr virus-positive diffuse large B-cell lymphoma: Results in a multi-center trial. Clinical and translational medicine 11 (9) (2022)
Jing Zheng, Yingyu Chen, Zhihong Zheng, Yanxin Chen, Yujuan Chai, Wenfeng Wang, Tetsuya Asakawa, Jian-da Hu
In Vitro Investigation of the Cytotoxic Activity of Emodin 35 Derivative on Multiple Myeloma Cell Lines. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Yu Zhang, Hao Zheng, Jinhua Ren, Xiaofeng Luo, Zhihong Zheng, Jing Zheng, Xiaoyun Zheng, Yi Chen, Zhizhe Chen, Jian-da Hu, Ting Yang
Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia. Hematological oncology 39 (3) (2021)
Jiazheng Li, Yan Huang, Yun Zhang, Jingjing Wen, Yanxin Chen, Lingyan Wang, Peifang Jiang, Jian-da Hu
Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma. Medical oncology (Northwood, London, England) 38 (4) (2021)
Yuwen Chen, Jian-da Hu, Yingyu Chen
Platelet desialylation and TFH cells-the novel pathway of immune thrombocytopenia. Experimental hematology & oncology 10 (1) (2021)
Yingyu Chen, Jing Zheng, Donghui Gan, Yanxin Chen, Na Zhang, Yuwen Chen, Zhenxing Lin, Wenfeng Wang, Haijun Chen, Donghong Lin, Jian-da Hu
E35 ablates acute leukemia stem and progenitor cells in vitro and in vivo. Journal of cellular physiology 235 (11) (2020)
Yanxin Chen, Peifang Jiang, Jingjing Wen, Zhengjun Wu, Jiazheng Li, Yuwen Chen, Lingyan Wang, Donghui Gan, Yingyu Chen, Ting Yang, Minhui Lin, Jian-da Hu
Integrated bioinformatics analysis of the crucial candidate genes and pathways associated with glucocorticoid resistance in acute lymphoblastic leukemia. Cancer medicine 9 (8) (2020)
Yingyu Chen, Jocelyn A Schroeder, Chunyan Gao, Jing Li, Jian-da Hu, Qizhen Shi
In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapy. Journal of cellular physiology 236 (1) (2020)
Xuqiao Mei, Yanxin Chen, Donghui Gan, Yingyu Chen, Lingyan Wang, Yanqin Cao, Zhengjun Wu, Weijuan Liu, Chenxing Zhao, Minhui Lin, Ting Yang, Jian-da Hu
Effect of nucleolin on adriamycin resistance via the regulation of B-cell lymphoma 2 expression in Burkitt's lymphoma cells. Journal of cellular physiology 234 (12) (2019)